✦ LIBER ✦

HER2 status and UPA/PAI-1 provide complementary information on patient outcome in node-negative breast cancer

✍ Scribed by I. Zemzoum; R. Kates; M. Schmitt; J. Ross; H. Höfler; M. Kiechle; N. Harbeck

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The complex between urokinase plasminoge

✍ P Manders; L Beex; V Tjan-Heijnen; P Span; N Grebenchtchikow; J Geurts-Moespot; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Clinical Significance of HER2-Positive a

✍ Gorshein, Elan; Klein, Paula; Boolbol, Susan K.; Shao, Theresa 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 262 KB

A combination of HER-2 status and the St

✍ Jong-Mu Sun; Wonshik Han; Seock-Ah Im; Tae-You Kim; In Ae Park; Dong-Young Noh; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Level-I evidence for prognostic impact o

✍ C. Thomssen; N. Harbeck; C. Meisner; A. Prechtl; M. Untch; B. Lisboa; H. Selbman 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Urokinase-type plasminogen activator (uP

✍ C. Thomssen; M. Vetter; D. Paepke; M. Schmidt; C. Veyret; D. Augustin; V. Hanf; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Comparison of microarray-based RNA expre

✍ Isabell D. Witzel; Karin Milde-Langosch; Ralph M. Wirtz; Claudia Roth; Maike Ihn 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 427 KB